FT Tech Tonic Defying death: The longevity lab
Dec 3, 2025
Boyang Wang, a venture capitalist and founder of the Immortal Dragons longevity fund, discusses Singapore's rise as a hub for longevity healthcare. He reveals how the city-state blends government initiatives and private investments to tackle ageing. Topics include ambitious biotech projects, regulatory advantages, and radical ideas like brain transplants. Wang emphasizes the importance of extending healthspan over lifespan, while experts highlight the growing consumer demand amidst limited scientific evidence, raising questions about regulation and societal shifts in an age of longevity.
AI Snips
Chapters
Transcript
Episode notes
White Light Rorschach Experience
- Michael Peel tried a Vibe Science neuromodulation eye mask that used white LEDs and sound to guide brain states.
- He experienced vivid imagery and deep relaxation despite the device emitting only white light.
Singapore As A Longevity Petri Dish
- Singapore functions as a real-time experiment in scaling longevity for an ageing, wealthy population.
- Government strategy, money and appetite for innovation combine to make it a global longevity hub.
Investor Ambition And Regulatory Flexibility
- Boyang Wang described his fund Immortal Dragons and investments across gene therapy and 3D bioprinting.
- He said Asia's regulatory leniency and Singapore's strategic location help run ambitious studies, including primate work.